Dashboard
Manage Tickers

NAUT Nautilus Biotechnology, Inc.

Nasdaq nautilus.bio


$ 1.36 $ 0.00 (0 %)    

Wednesday, 22-Oct-2025 08:06:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 610.33 $ 0.00 (0 %)
DIA $ 469.29 $ 0.00 (0 %)
SPY $ 671.52 $ 0.00 (0 %)
TLT $ 92.30 $ 0.00 (0 %)
GLD $ 371.61 $ 0.00 (0 %)
$ 1.42
$ 1.17
$ 1.35 x 2,222
$ 1.43 x 100
-- - --
$ 0.62 - $ 2.92
3,144,544
na
179.35M
$ 1.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 10-29-2024 09-30-2024 10-Q
5 07-30-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 09-18-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 21:06:08

nautilus-biotechnology-q2-2025-eps-012-beats-015-estimate
Nautilus Biotechnology Q2 2025 EPS $(0.12)...
07/31/2025 10:13:22

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

nautilus-biotechnology-enters-into-an-agreement-with-the-allen-institute-focused-on-investigating-the-connection-between-the-tau-protein-and-neurodegenerative-conditions-such-as-alzheimers-disease
Nautilus Biotechnology Enters Into An Agre...
07/30/2025 12:09:40

Allen Institute to employ Iterative Mapping, Nautilus' single-molecule proteomics method, to investigate connection between...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/29/2025 21:06:36

nautilus-biotechnology-q1-eps-013-beats-016-estimate-cash-balance-of-1928m
Nautilus Biotechnology Q1 EPS $(0.13) Beat...
04/29/2025 11:19:27

Core News & Articles
Earnings Scheduled For April 29, 2025
04/29/2025 08:32:27

nautilus-biotechnology-q4-gaap-eps-014-beats-016-estimate
Nautilus Biotechnology Q4 GAAP EPS $(0.14)...
02/27/2025 12:37:32

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

goldman-sachs-downgrades-nautilus-biotechnology-to-sell-lowers-price-target-to-175
Goldman Sachs Downgrades Nautilus Biotechn...
12/05/2024 17:42:51

Goldman Sachs analyst Matthew Sykes downgrades Nautilus Biotechnology (NASDAQ:NAUT) from Neutral to Sell and lowers the pric...

nautilus-biotechnology-reported-q3-cash-balance-of-2212m
Nautilus Biotechnology Reported Q3 Cash Ba...
10/29/2024 10:06:51

nautilus-biotechnology-q3-2024-gaap-eps-013-beats-017-estimate
Nautilus Biotechnology Q3 2024 GAAP EPS $(...
10/29/2024 10:05:56

nautilus-biotechnology-q2-eps-014-beats-016-estimate
Nautilus Biotechnology Q2 EPS $(0.14) Beat...
07/30/2024 10:09:06

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

guggenheim-initiates-coverage-on-nautilus-biotechnology-with-buy-rating-announces-price-target-of-6
Guggenheim Initiates Coverage On Nautilus ...
06/27/2024 11:09:10

Guggenheim analyst Subbu Nambi initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Buy rating and announces Pr...

jefferies-assumes-nautilus-biotechnology-at-hold-lowers-price-target-of-3
Jefferies Assumes Nautilus Biotechnology a...
06/03/2024 18:16:34

Jefferies analyst Tycho Peterson assumes Nautilus Biotechnology (NASDAQ:NAUT) with a Hold rating and lowers Price Target of $3.

nautilus-biotechnologys-cash-cash-equivalents-and-investments-were-2477m-as-of-march-31-2024
Nautilus Biotechnology's Cash, Cash Equiva...
04/30/2024 11:06:59

nautilus-biotechnology-q1-2024-gaap-eps-015-beats-017-estimate
Nautilus Biotechnology Q1 2024 GAAP EPS $(...
04/30/2024 11:06:26

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate o...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/29/2024 12:06:18

nautilus-biotechnology-entered-sales-agreement-with-cowen-to-zhares-sales-of-common-stock-having-aggregate-sales-proceeds-up-to-125m
Nautilus Biotechnology Entered Sales Agree...
02/28/2024 12:28:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION